This medication is a phosphate binder, prescribed to reduce serum phosphate in patients with end stage renal disease. It blocks the absorption of phosphate in the body.
PO- Initial dose is 750 mg to 1.5 g/day in divided doses.
It comes as a chewable tablet to take by mouth with food.
• It may cause dizziness, drowsiness. Do not drive a car or operate machinery while taking this medication.
• Caution needed while using in patients with history of ulcer, ulcerative colitis, Crohn's disease, bowel obstruction and during pregnancy.
• Gastrointestinal :
Stomach upset, vomiting, stomach pain, diarrhea and constipation.
• Miscellaneous : Problems with the dialysis graft, headache, dizziness and blurred vision.
Avoid excess dosage.
Store it at controlled room temperature (59° to 86°F). Protect from moisture.
Opportunistic infections are microbial infections that can cause disease in persons with a weak ...
The state health insurance programs provide health care support to the below poverty line (BPL) ...
There is a lining between the lungs and chest wall known as Pleura. The dismissal of pleura by a ...View All